| 开盘价:-- | 最高价:-- | 最低价:-- | 52周最高价:-- | 52周最低价:-- |
| 成交量:-- | 平均成交量:-- | 市值:-- | 市盈率:-- | 预期市盈率:-- |
| 每股收益:-- | 贝塔系数:-- | 股息:-- | 收益率:-- | 总股本:-- |
| 证券代码:rtrx | 公司名称:Travere Therapeutics, Inc. | 公司中文简称: |
| 公司简介： Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA. |
||
| 公司网站： http://www.travere.com |
||
| 公司地址： 3611 Valley Centre Drive Suite 300 San Diego |
||